Breast Cancer Treatment in the Era of Precision Medicine

Breast cancer is the most common cancer in women in the Western world.Treatment decisions in the adjuvant and metastatic setting are based on three immunohistochemistry markers, namely estrogen receptor (ER), progesterone receptor (PR), and Sheds human epidermal growth factor receptor 2 (HER2).Based on the St.Gallen consensus, four distinct subtype

read more



Efficacy and safety of salvage radiotherapy combined with endocrine therapy in patients with biochemical recurrence after radical prostatectomy: A systematic review and meta-analysis of randomized controlled trials

BackgroundThe addition of endocrine therapy to salvage radiotherapy (SRT) is expected to further improve the prognosis Power Entry Module of patients with biochemical recurrence of prostate cancer after radical prostatectomy (RP).The quantitative synthesis of clinical outcomes of SRT combined with endocrine therapy is limited.Whether salvage radiot

read more